← Open Payments lookup

CHRISTINA WEISS: Open Payments

NPI 1184187999 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$567 in 15 payments from 9 companies in 2025. Trend: 2023 $999 · 2024 $808 · 2025 $567

Food & beverage: $567
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.5$212
Teva Pharmaceuticals USA, Inc.1$113
Otsuka Pharmaceutical Development & Commercialization, Inc.1$88
Janssen Biotech, Inc.2$41
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$37
GENZYME CORPORATION1$23
Lilly USA, LLC1$21
QOL Medical, LLC1$16
Aimmune Therapeutics, Inc.1$16

Products named: AUSTEDO XR, ENTYVIO, TREMFYA, XIFAXAN, EOHILIA, DUPIXENT, OMVOH, Sucraid.

Industry payments across IN — which companies pay providers there.